Treatment to Regress to Normoglycemia in Women With a Recent History of GDM

Treatment to Regress to Normoglycemia in Women With a Recent History of GDM

Sham Comparator: Placebo
Weekly injections of placebo for 8 months total
Drug: Placebo semaglutide pen injector
Start injection of placebo semaglutide 0.25mg subcutaneously (SC) one a week for 4 weeks; step up to 0.5 mg SC QD for once a week for 4 weeks to a final dose of 1.0 mg semaglutide SQ weekly for 24 doses
Other Names:

Placebo Semaglutide 1mg
Placebo Ozempic

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 27, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments